Insights

Market commentary and guides

  • Ramsay Healthcare

    Ramsay Health Care is rated a buy with the stop loss at $37.05

  • CSL

    CSL is rated a buy.

  • China New Economy ETF

    VanEck China New Economy is rated a buy.

  • Global Healthcare ETF

    VanEck Global Healthcare Leaders is rated a buy.

  • S&P Biotech

    Global X S&P Biotech is under Algo Engine buy conditions.

  • Lynas

    ASX:LYN is under Algo Engine buy conditions.

  • Watch Last Night’s Webinar

    In case you missed it, you can watch last night’s webinar here.

  • S&P 500

    The S&P 500’s forward annual earnings per share are tracking at $260, $100 higher than six years ago. The P/E on a forward estimate…

  • ASX 200 Investor Model

    In the last 30 days, the following positions have been added to our longer-term investor model portfolio. We’ll take a closer look at the…